Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway

PLoS One. 2012;7(9):e45272. doi: 10.1371/journal.pone.0045272. Epub 2012 Sep 17.

Abstract

MSC display potent suppressive properties initially described a decade ago. More recently, MSC suppressive activities on T-cell effector pathways have been investigated. MSC modulate CD4 differentiation through different mechanisms depending on culture conditions and display disparate activities on T cells according to their differentiation status. A significant amount of evidence for MSC effects on Th17 cells revealed that MSC could be suppressive under diverse circumstances but also enhance Th17 cell activity under other conditions. In the present study, we investigated the suppressive effects of MSC on Th1 and Th17 subsets of T cells using T cells undergoing Th1 and Th17 polarization or mature Th1 and Th17 cells. MSC inhibited the proliferation of T cells during their differentiation toward Th1 cells and mature Th1 cells. This suppressive effect was maintained in a transwell cell culture insert demonstrating the major role played by soluble factors. Using the transwell cell separation barrier, we observed that MSC decrease the number of T cells undergoing Th17 differentiation whereas they did not affect IL-17 production by mature Th17, demonstrating the need for cell contact for suppressing Th17 cell function. Moreover, we reported that PD-L1 is highly expressed on MSC co-cultured with differentiating or polarized Th1 and Th17 cells. Using neutralizing antibodies specific for PD-L1 and PD-1 we showed that the mechanisms by which MSC mediate Th17 cell repolarization depend on PD-L1 expression on MSC. Taken together our results demonstrated a cell-to-cell contact depend mechanism in the selective immunosuppression of MSC on mature Th17 cells through up-regulation of PD-L1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing / pharmacology
  • B7-H1 Antigen / antagonists & inhibitors
  • B7-H1 Antigen / genetics*
  • B7-H1 Antigen / metabolism
  • Cell Communication / genetics
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Diffusion Chambers, Culture
  • Gene Expression Regulation / drug effects
  • Interleukin-17 / biosynthesis
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism*
  • Mice
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / genetics*
  • Programmed Cell Death 1 Receptor / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / genetics*
  • Th1 Cells / cytology
  • Th1 Cells / metabolism*
  • Th17 Cells / cytology
  • Th17 Cells / metabolism*

Substances

  • Antibodies, Neutralizing
  • B7-H1 Antigen
  • Cd274 protein, mouse
  • Interleukin-17
  • Pdcd1 protein, mouse
  • Programmed Cell Death 1 Receptor

Grant support

This work was supported by Inserm, the University of Montpellier I and grants from the Medical Research Foundation (projet FRM 2011 “Comité Languedoc-Roussillon-Rouergue (LRR)”), MED-03-2011 INOGTO201127 from Universidad de los Andes and funding from the European Community’s seventh framework programme for the collaborative project: “REGENER-AR:Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis” (contract no. 279174 EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.